Health Care & Life Sciences » Biotechnology | Basilea Pharmaceutica AG

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG
Stock Exchange Other OTC
EPS
$2.97
Market Cap
$406.5 M
Shares Outstanding
11.87 M
Public Float
-
Basilea Pharmaceutica AG
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
11.87 M
Public Float
-
Basilea Pharmaceutica AG
Stock Exchange SIX Swiss Exchange
EPS
CHF2.89
Market Cap
CHF400.59 M
Shares Outstanding
11.88 M
Public Float
10.74 M

Profile

Address
Grenzacherstrasse 487
Basel Basel-Stadt (Basle Town) 4058
Switzerland
Employees -
Website http://www.basilea.com
Updated 07/08/2019
Basilea Pharmaceutica AG is a biopharmaceutical company, with focus on bacterial infections, fungal infections and cancer. The company engages in the discovery, development, and commercialization of pharmaceutical products. Its products include Cresemba Isavuconazole, Zevtera/Mabelio Ceftobiprole, Toctino, and Microbiology Test.

Financials

View All

Domenico Scala
Chairman
Ronald Scott
Director